CRSP
Price
$44.02
Change
-$0.60 (-1.34%)
Updated
Dec 18, 11:36 AM (EDT)
62 days until earnings call
TECH
Price
$72.54
Change
-$2.73 (-3.63%)
Updated
Dec 18, 04:01 PM (EDT)
48 days until earnings call
Ad is loading...

CRSP vs TECH

Header iconCRSP vs TECH Comparison
Open Charts CRSP vs TECHBanner chart's image
CRISPR Therapeutics AG
Price$44.02
Change-$0.60 (-1.34%)
Volume$357
CapitalizationN/A
Bio-Techne
Price$72.54
Change-$2.73 (-3.63%)
Volume$300
CapitalizationN/A
CRSP vs TECH Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. TECH commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and TECH is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (CRSP: $44.63 vs. TECH: $75.27)
Brand notoriety: CRSP and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 80% vs. TECH: 65%
Market capitalization -- CRSP: $3.81B vs. TECH: $11.96B
CRSP [@Biotechnology] is valued at $3.81B. TECH’s [@Biotechnology] market capitalization is $11.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 3 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 3 green, 2 red.
According to our system of comparison, TECH is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 3 TA indicator(s) are bullish while TECH’s TA Score has 7 bullish TA indicator(s).

  • CRSP’s TA Score: 3 bullish, 7 bearish.
  • TECH’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TECH is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -8.32% price change this week, while TECH (@Biotechnology) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was +1.53%, and the average quarterly price growth was +3.09%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

TECH is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($12B) has a higher market cap than CRSP($3.81B). TECH YTD gains are higher at: -2.029 vs. CRSP (-28.706).
CRSPTECHCRSP / TECH
Capitalization3.81B12B32%
EBITDAN/AN/A-
Gain YTD-28.706-2.0291,415%
P/E RatioN/A79.23-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A420M-
FUNDAMENTALS RATINGS
CRSP vs TECH: Fundamental Ratings
CRSP
TECH
OUTLOOK RATING
1..100
6865
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9365
PRICE GROWTH RATING
1..100
8032
P/E GROWTH RATING
1..100
8314
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for CRSP (63). This means that TECH’s stock grew somewhat faster than CRSP’s over the last 12 months.

TECH's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as CRSP (100). This means that TECH’s stock grew similarly to CRSP’s over the last 12 months.

TECH's SMR Rating (65) in the Biotechnology industry is in the same range as CRSP (93). This means that TECH’s stock grew similarly to CRSP’s over the last 12 months.

TECH's Price Growth Rating (32) in the Biotechnology industry is somewhat better than the same rating for CRSP (80). This means that TECH’s stock grew somewhat faster than CRSP’s over the last 12 months.

TECH's P/E Growth Rating (14) in the Biotechnology industry is significantly better than the same rating for CRSP (83). This means that TECH’s stock grew significantly faster than CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPTECH
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+0.88%
BEAM - CRSP
72%
Closely correlated
-1.21%
PRME - CRSP
63%
Loosely correlated
-3.00%
NTLA - CRSP
62%
Loosely correlated
-1.87%
RXRX - CRSP
61%
Loosely correlated
-4.30%
EDIT - CRSP
61%
Loosely correlated
+2.70%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with NTLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-1.17%
NTLA - TECH
54%
Loosely correlated
-1.87%
XNCR - TECH
52%
Loosely correlated
+2.12%
QSI - TECH
51%
Loosely correlated
-8.67%
VIR - TECH
51%
Loosely correlated
-2.78%
CRSP - TECH
43%
Loosely correlated
+0.88%
More